Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major histocompatibility complex class II I-A (d haplotype), or I-A^d, is a mouse heterodimeric cell surface receptor crucial for the adaptive immune system, consisting of alpha (H2-Aa) and beta (H2-Ab1) chains (UniProt: P04224, P06340). It functions by presenting exogenous antigenic peptides to the T-cell receptors (TCR) of CD4+ T helper cells, a process fundamental to initiating immune responses (PubMed: 3062506). This specific MHC allele is characteristic of the d haplotype, found in mouse strains like BALB/c, and is widely used in immunological research to map T-cell epitopes, such as the Ovalbumin 323-339 peptide (IEDB). I-A^d plays a central role in mouse models of autoimmunity and infection, where its peptide-binding specificity determines disease susceptibility or resistance (PubMed: 2464525). Therapeutic interventions targeting I-A^d include monoclonal antibodies like MK-D6 and peptide-based vaccines designed to modulate or inhibit T-cell activation (PubChem: SID 472353431). Understanding the structural basis of I-A^d peptide binding is vital for developing immunotherapies that can either enhance or suppress specific immune pathways. The molecule is also a target in studies of graft-versus-host disease and transplant rejection in murine models.
Presents processed exogenous peptides to the T-cell receptor (TCR) of CD4+ T helper cells to initiate adaptive immune responses.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major histocompatibility complex class II I-A (d haplotype) (I-A^d).